<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Niu M</submitter><funding>National Key R&amp;amp;D Program of China</funding><funding>National Natural Science Foundation of China</funding><pagination>e3001113</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7939357</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(2)</volume><pubmed_abstract>Transforming growth factor-β (TGF-β) signaling plays a critical role in promoting epithelial-to-mesenchymal transition (EMT), cell migration, invasion, and tumor metastasis. ΔNp63α, the major isoform of p63 protein expressed in epithelial cells, is a key transcriptional regulator of cell adhesion program and functions as a critical metastasis suppressor. It has been documented that the expression of ΔNp63α is tightly controlled by oncogenic signaling and is frequently reduced in advanced cancers. However, whether TGF-β signaling regulates ΔNp63α expression in promoting metastasis is largely unclear. In this study, we demonstrate that activation of TGF-β signaling leads to stabilization of E3 ubiquitin ligase FBXO3, which, in turn, targets ΔNp63α for proteasomal degradation in a Smad-indepe</pubmed_abstract><journal>PLoS biology</journal><pubmed_title>Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosis.</pubmed_title><pmcid>PMC7939357</pmcid><funding_grant_id>2018YFC2000100</funding_grant_id><funding_grant_id>82073248</funding_grant_id><funding_grant_id>31701242</funding_grant_id><funding_grant_id>81520108020, 81830108 and 81861148031</funding_grant_id><pubmed_authors>He T</pubmed_authors><pubmed_authors>Yi Y</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Xiao ZJ</pubmed_authors><pubmed_authors>Niu M</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Chen YG</pubmed_authors><pubmed_authors>Guo R</pubmed_authors><pubmed_authors>Fu M</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Ding L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosis.</name><description>Transforming growth factor-β (TGF-β) signaling plays a critical role in promoting epithelial-to-mesenchymal transition (EMT), cell migration, invasion, and tumor metastasis. ΔNp63α, the major isoform of p63 protein expressed in epithelial cells, is a key transcriptional regulator of cell adhesion program and functions as a critical metastasis suppressor. It has been documented that the expression of ΔNp63α is tightly controlled by oncogenic signaling and is frequently reduced in advanced cancers. However, whether TGF-β signaling regulates ΔNp63α expression in promoting metastasis is largely unclear. In this study, we demonstrate that activation of TGF-β signaling leads to stabilization of E3 ubiquitin ligase FBXO3, which, in turn, targets ΔNp63α for proteasomal degradation in a Smad-indepe</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-07-13T03:04:51.172Z</modification><creation>2025-07-13T03:04:51.172Z</creation></dates><accession>S-EPMC7939357</accession><cross_references><pubmed>33626035</pubmed><doi>10.1371/journal.pbio.3001113</doi></cross_references></HashMap>